首页> 外文期刊>Asian Journal of Pharmaceutical and Clinical Research >INDUCTION OF LABOR BY PROSTAGLANDIN: A REVIEW FOR INDICATIONS AND RISK FOR CESAREAN SECTION
【24h】

INDUCTION OF LABOR BY PROSTAGLANDIN: A REVIEW FOR INDICATIONS AND RISK FOR CESAREAN SECTION

机译:前列腺素引产:对剖宫产指征和风险的回顾

获取原文
           

摘要

Objective: Labor induction by medication is now preferred by many obstetricians. The impact of induction remains ambiguous, although many studies and systematic reviews have been conducted. Few studies have reported for its better outcomes while other studies with poor outcomes. The objective of the study is to identify the common indications of induction and the risk of cesarean section after induction. Methods: Various standardized databases, such as Pub Med, Scopus, and Google Scholar, were used to collect the scientific studies, where prostaglandin was used as drug of choice for induction of labor. The key words used were induction of labor, indications of induction, induction by misoprostol, induction and risk of cesarean section, etc. The survey spans over 22 years of study articles published from the year 1995-2017. Result: A total of 112 studies have been included to analyze the indications and risk of cesarean section. The most common indication found in most of the studies was post-term pregnancy. The risk of cesarean section varied from 3% to 48.7%. The common reasons for which the cesarean section was planned were, failed induction, nonprogress of labor, fetal distress, and undiagnosed CPD. Conclusion: Most of the studies recommend induction of labor as a safer option with lower risk of c-section.
机译:目的:现在许多产科医生更喜欢用药物引产。尽管进行了许多研究和系统评价,但归纳的影响仍然不明确。很少有研究报告其疗效更好,而其他研究报告的效果较差。该研究的目的是确定诱导的常见指征以及诱导后剖宫产的风险。方法:使用各种标准化数据库(例如Pub Med,Scopus和Google Scholar)收集科学研究,其中前列腺素被用作引产的首选药物。使用的关键词是引产,引产的迹象,米索前列醇的引产,引产和剖宫产的风险等。该调查涵盖了从1995年至2017年发表的22年研究文章。结果:共纳入112项研究,以分析剖宫产的指征和风险。在大多数研究中发现的最常见的适应症是足月妊娠。剖宫产的风险从3%到48.7%不等。计划剖宫产的常见原因有:引产失败,分娩不进展,胎儿窘迫和CPD未诊断。结论:大多数研究建议引产是一种安全的选择,可降低剖腹产的风险。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号